Accessibility Menu
Genetic Technologies logo

Genetic Technologies

(OTC) GNTLF

Current Price$0.00
Market Cap$1.30K
Since IPO (2003)-100%
5 Year-100%
1 Year-100%
1 Month-100%

Genetic Technologies Financials at a Glance

Market Cap

$1.30K

Revenue (TTM)

A$13.70M

Net Income (TTM)

-A$22.39M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-24997.15 (Low)

Price

$0.00

Volume

2,000

Open

$0.00

Previous Close

$1.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $1.00

Estimated Earnings Date

Aug 27, 2026

GNTLF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genetic Technologies

Industry

Life Sciences Tools and Services

Employees

58

CEO

Simon Morriss

Headquarters

Fitzroy, VIC 3065, AU

GNTLF Financials

Key Financial Metrics (TTM)

Gross Margin

51%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

0%

Return on Capital

-6%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.30K

Shares Outstanding

1.34B

Volume

2.00K

Avg. Volume

0

Financials (TTM)

Gross Profit

A$3.90M

Operating Income

-A$12.21M

EBITDA

-A$11.43M

Operating Cash Flow

-A$9.68M

Capital Expenditure

-A$32.97K

Free Cash Flow

-A$9.71M

Cash & ST Invst.

A$1.04M

Total Debt

A$875.19K

Genetic Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

A$413.95K

-90.0%

Gross Profit

A$413.95K

+126.8%

Gross Margin

100.00%

N/A

Market Cap

$1.30K

N/A

Market Cap/Employee

$23.64

N/A

Employees

55

N/A

Net Income

-A$4.09M

+25.2%

EBITDA

-A$1.33M

+73.7%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

A$512.94K

-88.4%

Accounts Receivable

A$145.24K

-95.0%

Inventory

A$0.00

-100.0%

Long Term Debt

A$0.00

-100.0%

Short Term Debt

A$500.00K

+76.1%

Return on Assets

-1.94%

N/A

Return on Invested Capital

-6.13%

N/A

Free Cash Flow

-A$78.35K

+97.1%

Operating Cash Flow

-A$71.27K

+97.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MRCHFH.U. Group Holdings, Inc.
$20.26-3.52%
EVOTFEvotec SE
$6.69+0.00%
RYHTYRyman Healthcare Limited
$6.11+0.00%
CMOPFCosmo Pharmaceuticals N.V.
$93.62+5.19%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$16.62-0.01%
STISolidion Technology
$22.71+3.51%
BBBlackBerry
$10.34+0.02%
TAT&T
$22.77-0.03%

Questions About GNTLF

What is the current price of Genetic Technologies?

Genetic Technologies is trading at $0.00 per share.

What is the 52-week range for Genetic Technologies?

Over the past 52 weeks, Genetic Technologies has traded between $0.00 and $1.00.

How much debt does Genetic Technologies have?

As of the most recent reporting period, Genetic Technologies reported total debt of A$584.49K.

How much cash does Genetic Technologies have on hand?

Genetic Technologies reported A$681.61K in cash and cash equivalents in its most recent financial results.

What is Genetic Technologies’s dividend yield?

Genetic Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.